Clinical Trial Update: HDDO-1614 Intervention Trial [Phase 1]

View source ↗

Summary

Phase 1 trial HDDO-1614 in osteoporosis has completed, with Hyundai Pharmaceutical Co., LTD. as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• HDDO-1614

Snippet

Sponsor: Hyundai Pharmaceutical Co., LTD. | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED